Shockwave Treatment Improves Chronic Pelvic Pain Syndrome in Men
Title of study: PD32-03 Case Series of Low Intensity Shock Wave Therapy for Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Authors: Daniel Shoskes and Brandon Mooney
Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) is a complex and difficult-to-treat condition affecting men. Low-Intensity Shock Wave (LiSW) therapy has emerged as a promising treatment option, and this study aimed to investigate its effectiveness and safety in CP/CPPS patients.
The study involved 14 men diagnosed with CP/CPPS who underwent weekly LiSW treatment using the Urogold 100 machine. Symptom severity was measured before and after treatment using the National Institute of Health Chronic Prostatitis Symptom Index (CPSI), and patients were clinically phenotyped using the UPOINT system.
The results showed that LiSW therapy significantly improved the total CPSI score in the majority of patients, with 9 out of 14 reporting a >6 point drop in CPSI. Pain and quality of life scores also improved significantly.
All responders had pelvic floor spasm, which suggests that LiSW therapy may be particularly effective in treating pain from trigger points. Shockwave therapy was found to be safe and well-tolerated, with no reported side effects.
In conclusion, this study demonstrates that LiSW therapy is an effective and safe treatment option for CP/CPPS patients, especially those with pelvic floor spasm. This non-invasive therapy has the potential to improve the quality of life of men suffering from this debilitating condition.